Unlocking advanced heart health insights for everyone
CONNEQT Pulse goes beyond blood pressure, putting clinical-grade arterial health insights in your hands
Powered by Pulse Wave Analysis (PWA), CONNEQT Pulse deciphers the hidden signals in each heartbeat to generate vascular biomarkers that go beyond traditional blood pressure, making clinical-grade arterial health insights accessible for everyday use.
Not all blood pressure readings are created equally
Traditional blood pressure cuffs give you a single pressure reading, but they miss the full picture of how your arteries are functioning. CONNEQT Pulse goes deeper by analyzing arterial waveforms to assess your vascular health in real-time.
How flexible or stiff your arteries are
(a key factor in cardiovascular risk)
How well your arteries respond to each heartbeat
(vascular compliance)
Early warning signs of hypertension, arterial aging, and cardiovascular disease
By understanding these patterns, you gain a proactive edge in optimizing your heart health.
Research-backed health insights
Traditional blood pressure readings only tell part of the story. CONNEQT Pulse uses Pulse Wave Analysis (PWA) to measure key vascular biomarkers that predict cardiovascular (CV) risk before symptoms appear.
- Central Blood Pressure (CBP) – A stronger predictor of heart disease; a 4-mmHg reduction lowers CV risk by 20%.
- Central Pulse Pressure (CPP) – Elevated levels (>50 mmHg) increase CV risk 2–3x.
- Augmentation Pressure (AP) & Augmentation Index (AIx) – Higher values increase CV risk by up to 40%.
- Subendocardial Viability Ratio (SEVR) – Lower SEVR reduces heart oxygen supply, raising CV risk.
By tracking these biomarkers, the CONNEQT Pulse helps detect hidden risks, optimize heart health, and empower better cardiovascular decisions.
Clinically validated. Trusted by experts.
CONNEQT Pulse is powered by SphygmoCor® technology, the gold standard in arterial health assessment, used by leading cardiovascular researchers, pharmaceutical companies, and healthcare institutions worldwide.
- Used by Mayo Clinic, Weill Cornell, and top research hospitals.
- Integrated into clinical trials for major pharmaceutical companies.
- Validated by peer-reviewed research on arterial health and cardiovascular risk assessment.
“SphygmoCor has transformed the way we treat hypertension. By using central aortic pressure readings, we can target treatments more precisely, improving patient outcomes without adding complexity to our workflow”
Dr. Mark C. Houston, MD
Director, Hypertension Institute and Vascular Biology
Medical Director of Division of Human Nutrition
Medical Director of Clinical Research ASH Specialist in Clinical Hypertension (FASH)
Vanderbilt University School of Medicine Associate Clinical Professor of Medicine (1990-2012)
“The CONNEQT Pulse gives a more complete and precise picture of arterial health you can actually act on with dietary and lifestyle changes.”
Dr. Joseph Raffaele, MD
Founder and CEO, Raffaele Medical
American College of Physicians member
American Board of Age Management Medicine Diplomat
Board certified in internal medicine.
"The CONNEQT PULSE is an easy-to-use, all-in-one device that provides detailed insights of our cardiovascular health"
Dr Carmel McEniery, PhD
Senior Research Associate University of Cambridge
Investigator and author of numerous arterial health studies, including Whitehall II (cognition & arterial stiffness), ACCT (vascular aging), and POPPY (pre-eclampsia & cardiovascular health).
